Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2009-02-01 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-DENIS (93200), Seine-Saint-Denis
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DARONDEAU : revenue, balance sheet and financial ratios
SELARL PHARMACIE DARONDEAU is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-DENIS (93200),
this company of category PME
shows in 2024 a net income positive of 72 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DARONDEAU (SIREN 510380801)
Indicator
2024
2023
2022
2021
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
72 049 €
49 807 €
245 206 €
160 521 €
6 126 €
54 069 €
48 573 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE DARONDEAU generates positive net income of 72 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 49 k€ -> 72 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
72 049 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 190%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
190.07%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
25.269%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2021
2022
2023
2024
Debt ratio
268.871
186.921
444.728
213.309
150.094
266.13
190.07
Financial autonomy
20.872
26.196
12.251
23.282
31.01
21.118
25.269
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
190.072024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average+8 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE DARONDEAU (190.07) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
25.27%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Watch
In 2024, the financial autonomy of SELARL PHARMACIE DARONDEAU (25.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 277.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2021
2022
2023
2024
Liquidity ratio
270.08
270.29
214.546
299.005
354.919
334.369
277.783
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
277.782024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of SELARL PHARMACIE DARONDEAU (277.78) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELARL PHARMACIE DARONDEAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DARONDEAU is estimated at
1 005 857 €
(range 700 463€ - 1 504 820€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
700k€1005k€1504k€
1 005 857 €Range: 700 463€ - 1 504 820€
NAF 5 année 2024
Valuation method used
Net Income Multiple
72 049 €
×
14.0x
=1 005 857 €
Range: 700 463€ - 1 504 820€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DARONDEAU with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DARONDEAU
What is the revenue of SELARL PHARMACIE DARONDEAU ?
The revenue of SELARL PHARMACIE DARONDEAU is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DARONDEAU profitable?
Yes, SELARL PHARMACIE DARONDEAU generated a net profit of 72 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DARONDEAU ?
The headquarters of SELARL PHARMACIE DARONDEAU is located in SAINT-DENIS (93200), in the department Seine-Saint-Denis.
Where to find the tax return of SELARL PHARMACIE DARONDEAU ?
The tax return of SELARL PHARMACIE DARONDEAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DARONDEAU operate?
SELARL PHARMACIE DARONDEAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart